Spirit AeroSystems (NYSE:SPR) stock is losing altitude on Monday after an Alaska Airlines (NYSE:ALK) plane experienced a mid-air blowout over the weekend.
That saw a door plug on one of its flights blow out only six minutes after the plane had departed. Fortunately, the plane wasn’t high enough yet for the depressurization of the cabin to matter, and the two seats next to the panel were empty.
Investigations are underway following the blowout, and some investors are worrying about SPR stock as a result. However, it’s also worth noting that the plane that experienced the problem is a Boeing (NYSE:BA) 737 MAX 9, which SPR partially manufactures.
It’s possible that the fault for the door plug blowout doesn’t lie on Alaska Airlines. Instead, it seems likely that Boeing may bear the blame for the accident. No matter the case, investors in these stocks are spooked by today’s news.
How This Affects SPR and BA Stock
With this blowout comes sharp drops in trading prices for both companies’ shares. This has SPR stock falling 14.2% as of Monday morning. At that same time, shares of BA stock have experienced a 7.7% drop today.
Depending on the investigation results, SPR stock may recover from this news faster than Boeing.
Investors looking for more of the hottest stock market stories are in the right place!
We have all of the latest stock market news that traders need to know about on Monday! That includes what’s going on with shares of LumiraDx (NASDAQ:LMDX) stock, Cellectar Biosciences (NASDAQ:CLRB) stock and Harpoon Therapeutics (NASDAQ:HARP) stock today. You can catch up on all of these topics at the following links!
More Stock Market News for Monday
- Why Is LumiraDx (LMDX) Stock Down 13% Today?
- Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today?
- Why Is Harpoon Therapeutics (HARP) Stock Up 111% Today?
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
